Price range: $59.99 through $139.99
GLP-1-S is a synthetic peptide analog of the endogenous incretin hormone glucagon like peptide 1 (GLP 1). In research contexts, it has been studied as a long acting GLP 1 receptor agonist that binds to and activates GLP 1 receptors involved in metabolic signaling pathways. Its molecular structure is designed to prolong receptor engagement, allowing sustained investigation of its effects on pathways related to glucose metabolism and appetite regulation.
Price range: $59.99 through $139.99
GLP-1-S is a synthetic peptide analog of the endogenous incretin hormone glucagon like peptide 1 (GLP 1). In research contexts, it has been studied as a long acting GLP 1 receptor agonist that binds to and activates GLP 1 receptors involved in metabolic signaling pathways. Its molecular structure is designed to prolong receptor engagement, allowing sustained investigation of its effects on pathways related to glucose metabolism and appetite regulation.
GLP-1-S is a synthetic peptide analog of the endogenous incretin hormone glucagon like peptide 1 (GLP 1). In research contexts, it has been studied as a long acting GLP 1 receptor agonist that binds to and activates GLP 1 receptors involved in metabolic signaling pathways. Its molecular structure is designed to prolong receptor engagement, allowing sustained investigation of its effects on pathways related to glucose metabolism and appetite regulation.
GLP-1-S mimics the action of GLP-1, a hormone released by enteroendocrine cells in response to nutrient intake. By binding to and activating GLP-1 receptors, GLP-1-S influences biochemical pathways associated with metabolic regulation. These pathways include glucose-dependent insulin response modulation, reduced glucagon secretion in hyperglycemic conditions, and slowed gastric emptying, which collectively support changes in appetite and energy intake patterns observed in controlled studies.
The peptide’s chemical modifications prolong its half-life in circulation compared to native GLP-1, making it suited to extended exposure in experimental models.
Because GLP-1-S acts as a GLP-1 receptor agonist, its effects in research systems appear to involve multiple metabolic signaling pathways:
These mechanisms are explored in controlled preclinical and clinical research settings, illustrating coordinated regulatory effects at multiple biochemical and signaling nodes.
Research shows GLP-1-S engages pathways associated with appetite reduction, hunger modulation, and decreased energy intake in controlled studies. This includes effects on brain regions associated with cravings and reward signaling.
In experimental use, GLP-1-S supports pathways involved in glucose regulation via enhanced insulin secretion and glucagon suppression in glucose-dependent contexts, which are core areas of metabolic research.
GLP-1-S’s GLP-1 receptor engagement has been studied in models examining cardio-metabolic risk pathways. Controlled research data indicate it may interact with signaling cascades relevant to cardiovascular outcomes and inflammatory modulation in experimental systems.
Beyond appetite and glucose pathways, GLP-1-S has also been studied in preclinical contexts exploring adipose tissue signaling, energy expenditure modulation, and mitochondrial biogenesis in laboratory models.
Peptide Type: Synthetic GLP-1 receptor agonist analogue
Target System: Glucagon-like peptide-1 receptors
Primary Mechanistic Domains: Metabolic signaling, appetite modulation, glucose response pathways
Form: Research preparations vary by formulation
Stability: Designed for prolonged receptor engagement in experimental studies
What is GLP-1-S?
GLP-1-S is a synthetic peptide analogous to GLP-1 and is studied as a receptor agonist that engages metabolic signaling pathways relevant to glucose and appetite regulation.
Why does GLP-1-S support appetite and energy intake pathways?
By activating GLP-1 receptors in systems tied to hunger and satiety signals, GLP-1-S influences signaling that is associated with appetite and food intake patterns in controlled research.
How does GLP-1-S engage glucose-related pathways?
GLP-1-S’s activation of GLP-1 receptors supports glucose-dependent insulin secretion and suppression of glucagon release, key signals investigated in metabolic research.
Can GLP-1-S influence cardiovascular-related mechanisms?
Research has explored GLP-1-S’s engagement with pathways associated with cardiovascular outcomes in controlled settings, suggesting potential integrated signaling responses.
Are mechanisms other than appetite and glucose being studied?
Yes. Preclinical work has examined GLP-1-S’s interactions with adipose signaling, inflammation regulation, and cellular energy pathways in experimental models.
This product is intended strictly for laboratory research and scientific investigation purposes only. GLP-1-S and its individual peptide components are not approved by the United States Food and Drug Administration for human or veterinary use. They are not intended for use as drugs, dietary supplements, cosmetics, or food products.
Our products are produced using a freeze-drying process (lyophilization), which helps maintain their integrity and stability during transit, typically for up to 3–4 months.
After the peptides are reconstituted (mixed with bacteriostatic water), they should be kept refrigerated to preserve their quality. Once in liquid form, they generally remain stable for up to 30 days when stored properly.
Lyophilization—also referred to as cryodesiccation—is a dehydration method where the material is first frozen and then exposed to low pressure. This allows moisture to transition directly from solid to vapor, leaving behind a dry, stable compound in the form of a light, crystalline powder. In this state, the product can be kept at room temperature until it is ready to be reconstituted.
Upon receiving your peptides, it is recommended to protect them from heat and light exposure. For short-term use (ranging from a few days to several weeks), refrigeration below 4°C (39°F) is suitable. Lyophilized products can also tolerate room temperature storage for a limited period if they will be used relatively soon.
For extended storage—spanning several months or longer—freezing is advised. Ideally, peptides should be kept at approximately -80°C (-112°F) to best maintain long-term stability
